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Abstract: Menopause alters body composition by increasing fat mass. Menopausal hormone
therapy (MHT) is associated with decreased total and visceral adiposity. It is unclear whether
MHT favorably affects energy intake. We aimed to assess in the OsteoLaus cohort whether total
energy intake (TEI) and/or diet quality (macro- and micronutrients, dietary patterns, dietary scores,
dietary recommendations)—evaluated by a validated food frequency questionnaire—differ in 839
postmenopausal women classified as current, past or never MHT users. There was no difference
between groups regarding TEI or consumption of macronutrients. After multivariable adjustment,
MHT users were less likely to adhere to the unhealthy pattern ‘fat and sugar: Current vs. never
users [OR (95% CI): 0.48 (0.28–0.82)]; past vs. never users [OR (95% CI): 0.47 (0.27–0.78)]. Past
users exhibited a better performance in the revised score for Mediterranean diet than never users
(5.00 ± 0.12 vs. 4.63 ± 0.08, p < 0.04). Differences regarding compliance with dietary recommendations
were no longer significant after adjustment for covariates. Overall, these results argue against a major
role of TEI and diet quality as possible mediators of the MHT metabolic benefits. Future research on
this relationship should focus on other potential targets of MHT, such as resting energy expenditure
and physical activity.
Keywords: menopause; estrogens; estrogen deficiency; visceral fat; menopausal hormone therapy;
energy intake; macronutrients; dietary patterns; dietary recommendations
1. Introduction
Among the most pronounced expressions of sexual dimorphism, menopause or more accurately
the menopausal transition (MT) is a phase of progressive gonadal insufficiency occurring selectively in
women and evolving towards the permanent cessation of menses at a mean age of 50–52 years [1].
Estrogen deficiency is the principal underlying hormonal consequence. In addition to the well-known
vasomotor symptoms [2] and accelerated bone loss [3], MT significantly alters body composition with
opposite effects on fat and lean body mass [4]. The Study of Women’s Health Across the Nation cohort,
which followed longitudinally 1246 women of different ethnic backgrounds, confirmed that both the
accelerated fat mass (FM) gain and the decline in lean mass are menopause-related and not merely
age-dependent [5]. Several small interventional studies evaluated whether these changes are reversible
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with menopausal hormone therapy (MHT) and by what mechanisms [6]. These studies have yielded
mixed results.
Recently, we analyzed the postmenopausal women of OsteoLaus cohort and demonstrated that
MHT prevents the increase in fat mass, and, in particular, the increase of visceral adipose tissue
(VAT) [6]. It is still unclear whether these benefits result from the direct effect of estrogens on fat tissue
and muscles [7,8], or whether changes in behavior influence the balance between energy intake and
expenditure [9]. In favor of the latter hypothesis, evidence suggests that female reproductive hormones
modulate the physiologic control of food intake [10,11]. Caloric intake progressively declines during
the follicular phase following an increase of serum estradiol (E2) [12]. Loss of estrogens following
ovariectomy elicits overeating in animal models, including monkeys and rats [13], a finding partly
reversed by E2 administration [12,14]. Studies in transgenic mice highlighted the activation of estrogen
receptor type-α in the hypothalamic pro-opiomelanocortin neurons of the arcuate nucleus as the
principal mechanism underlying the anorectic effects of E2 [15]. There is, however, a dearth of research
exploring whether exogenous estrogens, and in particular MHT, affect the neuroendocrine control of
eating in humans as well.
An initial evaluation of the OsteoLaus cohort showed no difference in total caloric intake between
postmenopausal women on MHT and those who were MHT-naïve [6]. Given the promising preclinical
data mentioned above, we hypothesized that improving the quality of nutrition can contribute to the
reduction of FM and VAT induced by MHT. The objective of this study was to explore whether relative
macronutrient intake, adherence to healthy eating habits and other qualitative elements contribute to
the body composition advantages in postmenopausal women of the OsteoLaus cohort taking MHT.
2. Material and Methods
2.1. Setting
OsteoLaus is a sub-study of the CoLaus/PsycoLaus study, an ongoing prospective study aiming
to assess the determinants of cardiovascular disease using a population-based sample drawn from
the city of Lausanne, Switzerland [16]. Between September 2009 and September 2012, all women
aged between 50 and 80 years from the CoLaus/PsycoLaus study were invited to participate in the
OsteoLaus sub-study and approximately 85% accepted. The primary aims of OsteoLaus are to compare
different models of fracture risk prediction and to assess the relationship between osteoporosis and
cardiovascular diseases [17]. CoLaus and OsteoLaus studies were approved by the Institutional Ethics
Committee of the University of Lausanne. All participants signed an informed consent form.
2.2. Participants
Of the 1475 postmenopausal women included in OsteoLaus, 1053 had a body composition assessed
by Dual X-ray absorptiometry (Discovery A System, Hologic, Inc., Marlborough, MA, USA). Women
treated with estrogen-mediated effects (aromatase inhibitors, tamoxifen, antiandrogens) were excluded
from this analysis [18]. The participants were subsequently divided into three groups: Current (CU),
past (PU) and never users (NU) of MHT. CU were taking MHT at trial entry or discontinued treatment
less than six months before trial entry. PU followed MHT for at least six months (otherwise considered
as NU) and discontinued MHT at least six months before trial entry (otherwise considered as CU) [18].
2.3. Dietary Data
Dietary data for this group were derived from the nearest CoLaus visit (second visit) who
took place within six months before the OsteoLaus inclusion. Dietary intake was assessed using a
self-administered, semi-quantitative Food Frequency Questionnaire (FFQ), which also includes portion
size and has been validated against 24 h recalls among 626 volunteers from the Geneva population [19].
Data derived from this FFQ have contributed to local and worldwide analysis [20,21]. Concisely, this
FFQ assesses the dietary intake of the previous four weeks and consists of 97 different food items that
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account for more than 90% of the intake of calories, proteins, fat, carbohydrates, alcohol, cholesterol,
vitamin D and retinol, and 85% of fiber, carotene and iron. Conversion of the FFQ responses into
nutrients was based on the French CIQUAL food composition table. Total energy intake (TEI) was
computed, including alcohol consumption.
Dietary patterns were derived using principal components analysis (PCA) based on food
consumption frequencies. Food consumption frequencies were defined as follows: Never during the
past four weeks = 0; 1 time per month = 1/28; 2–3 times per month = 2.5/28; 1–2 times per week = 1.5/7;
3–4 times per week = 3.5/7; once per day = 1, and ≥ twice per day = 2.5. We identified three dietary
patterns: “Meat and fries”, “fruits and vegetables” and “fatty and sugary”. A detailed description of
the assessment and characteristics of the dietary patterns is provided elsewhere [22].
Three health diet scores were additionally computed: Two Mediterranean diet scores (the
classic [23] and a more recent one adapted to Switzerland [24], as well as the Alternate Healthy Eating
Index (AHEI) developed by the Harvard School of Public Health [25]. The particularities of each score,
as well as their validation in a Swiss population, have been previously reported [26]. Dietary patterns
and diet scores were further categorized into quintiles, and the prevalence of participants in the highest
quartile, according to MHT group was assessed.
Participants were dichotomized according to whether they followed the dietary recommendations
for fruits, vegetables, meat, fish and dairy products from the Swiss Society of Nutrition (Schweizerische
Gesellschaft für Ernährung SGE, 2013). The recommendations were ≥2 fruit portions/day; ≥3 vegetable
portions/day; ≤5 meat portions/week; ≥1 fish portion/week and ≥3 dairy products portions/day [27].
As the FFQ queried about fresh and fried fish, two categories were considered: One included and
one excluded fried fish. Participants were further dichotomized if they complied with at least three
recommendations or not; two categories of compliance with at least three recommendations were
created, depending on the type of fish consumed (all or fresh only).
2.4. Covariates
Bodyweight and height were measured using standard procedures [16], and body mass index
(BMI) was defined as weight (kg)/height (m)2. Overweight was defined as 25 ≤ BMI < 30 kg/m2 and
obesity as BMI ≥ 30 kg/m2. Smoking status was defined as never, former (irrespective of the time
since quitting) and current (irrespective of the amount smoked). Diabetes status was defined as a
fasting plasma glucose ≥7.0 mmol/L and/or presence of insulin or oral antidiabetic drugs. Physical
activity was estimated by a self-administered physical activity frequency questionnaire (PAFQ). The
questionnaire listed 70 activities or groups of activities and was validated against the measurement of
energy expenditure by heart rate monitor with satisfactory correlations (r = 0.76) between the two
methods [28]. For this analysis, only sedentary status (yes/no) was used. Sedentary status was defined
when the participant spent less than 10% of her total daily energy expenditure in activities with an
intensity over four basal metabolic rate equivalents. Trained collaborators performed the examinations,
interviewed the participants, and checked the self-administered questionnaires for completion.
2.5. Statistical Analysis
Statistical analyses were conducted using Stata v15.1 (StataCorp, College Station, TX, USA)
for Windows. Descriptive results were expressed as a number of participants (percentage) for
categorical variables or as average ± standard deviation for continuous variables. Bivariate analyses
were conducted using chi-square for categorical variables and Kruskal-Wallis test for continuous
variables. Multivariable analyses (adjusting for total energy intake, age, education, BMI category,
sedentary level and diabetes) were conducted using analysis of variance and results were expressed as
adjusted average ± standard error. Statistical significance was considered for a two-tailed test with a
p-value < 0.05.
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3. Results
3.1. Selection of Participants and Characteristics of the Final Sample
Out of the initial sample of 1053 women, 214 (20.3%) were excluded mainly due to absent
or incomplete dietary data. The detailed reasons for exclusion are illustrated in Figure 1. The
characteristics of included and excluded participants are summarized in Supplementary Table S1.
Excluded subjects were significantly older, less educated and more frequently obese and diabetic.
The characteristics of the included participants according to MHT status, are shown in Table 1. The
three groups differed in age (PU > CU > NU, p < 0.001). CU were significantly thinner than NU
(−0.9 kg/m2), which was also reflected by means of a lower percentage of obesity in this group. There
was no significant difference in terms of educational level or current/past smoking. CU tended to
be less sedentary, and be associated with a lower incidence of diabetes, though without reaching
statistical significance.
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Table 1. Characteristics of the participants according to menopausal hormone therapy.
Characteristic Never Current Past p-Value
Number 432 180 227
Age (years) 60.8 ± 7.5 62.5 ± 6.8 66.9 ± 6.2 <0.001
Educational level (%) 0.177
University 71 (16.4) 34 (18.9) 36 (15.9)
High school 115 (26.6) 47 (26.1) 58 (25.6)
Apprenticeship 174 (40.3) 77 (42.8) 81 (35.7)
Mandatory 72 (16.7) 22 (12.2) 52 (22.9)
Smoking categories (%) 0.413
Never 178 (41.2) 81 (45.0) 108 (47.6)
Former 167 (38.7) 69 (38.3) 85 (37.4)
Current 87 (20.1) 30 (16.7) 34 (15.0)
Body mass index (kg/m2) 25.6 ± 4.1 24.7 ± 3.9 25.4 ± 4.1 0.032
BMI categories (%) 0.047
Normal 207 (47.9) 101 (56.1) 106 (46.7)
Overweight 151 (35.0) 63 (35.0) 91 (40.1)
Obese 74 (17.1) 16 (8.9) 30 (13.2)
Sedentary status (%) 279 (64.6) 109 (60.6) 155 (68.3) 0.268
Diabetes (%) 24 (5.6) 5 (2.8) 11 (4.9) 0.334
BMI, body mass index. Results are expressed as a number of participants (percentage) for categorical variables and
as average ± standard deviation for continuous variables. Between-group comparisons performed using chi-square
for categorical variables and analysis of variance for continuous variables. Statistically significant p-values are
highlighted in bold.
3.2. Menopausal Hormone Therapy and Dietary Intake
Data on the consumption of different nutrients according to MHT status are displayed in Table 2.
The three groups did not significantly differ regarding TEI. Analysis of macronutrients showed similar
results between groups except for higher vegetal protein and fiber intake in PU, which did not persist
after multivariate adjustment. In particular, CU did not exhibit a lower consumption of carbohydrates
or saturated fatty acids (SFA) compared with NU. PU significantly exceeded the other groups in terms
of iron intake, as well as consumption of fruits when combined with juices.
3.3. Menopause Hormone Therapy and Dietary Patterns
Three patterns were examined, as recently identified in the French-speaking population of
Switzerland [20]: Meat and chips, fruits and vegetables, and fat and sugar. Adherence to each dietary
pattern according to MHT status is shown in Table 2 (negative scores indicating low adherence and vice
versa), whereas the prevalence rate ratios (PRRs, and 95% confidence interval) of being in the highest
quintile relative to the other four are illustrated in Table 3. Overall, all groups were associated with low
adherence to the meat and chips. A significantly higher adherence for the fruits and vegetables was
observed in PU, a finding that was lessened following multivariate adjustments. Both MHT groups
exhibited a tendency to negative scores for the fat and sugar pattern in contrast to NU. When focusing
the analysis to the probability of being in the highest quintile for this pattern (Table 3), both CU and
PU had significantly lower PRRs in comparison to NU.
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Table 2. Dietary intake according to menopausal hormone therapy.
Bivariate Analysis Multivariable Analysis
Never Current Past p-Value Never Current Past p-Value
Number 432 180 227 432 180 227
Total energy intake (kcal) 1673 ± 546 1699 ± 565 1766 ± 578 0.121 - - - -
Macronutrients (g/day)
Total protein 64.0 ± 23.2 64.0 ± 23.0 64.9 ± 24.5 0.969 64.8 ± 0.6 64.2 ± 1.0 63.2 ± 0.9 0.358
Vegetal protein 20.4 ± 9.4 19.8 ± 8.5 21.5 ± 8.7 0.039 20.7 ± 0.3 19.9 ± 0.4 20.8 ± 0.4 0.201
Animal protein 43.6 ± 19.2 44.2 ± 19.5 43.3 ± 20 0.847 44.1 ± 0.7 44.3 ± 1.1 42.4 ± 1.1 0.356
Carbohydrates 200.7 ± 81.4 200.7 ± 83.1 212.2 ± 83.2 0.154 204.8 ± 2.0 201.7 ± 3.0 204.0 ± 2.8 0.699
Disaccharides 104.1 ± 48.3 108.2 ± 58.4 113.2 ± 56.5 0.232 106.2 ± 1.9 108.3 ± 2.9 109.0 ± 2.7 0.663
Polysaccharides 96.2 ± 52.8 92.1 ± 48.0 98.6 ± 46.8 0.254 98.1 ± 1.7 92.9 ± 2.6 94.5 ± 2.5 0.206
Total fat 63.7 ± 23.6 64.9 ± 24.5 66.4 ± 26.6 0.534 64.9 ± 0.7 65.0 ± 1.1 64.1 ± 1.0 0.778
SFA 23.2 ± 9.7 23.9 ± 11.0 23.7 ± 10.4 0.783 23.7 ± 0.3 23.9 ± 0.5 22.7 ± 0.5 0.152
MUFA 25.8 ± 10.3 26.4 ± 10.2 27.1 ± 12.3 0.581 26.2 ± 0.4 26.4 ± 0.6 26.3 ± 0.5 0.954
PUFA 8.9 ± 4.3 8.9 ± 3.6 9.4 ± 4.3 0.156 9.1 ± 0.2 8.9 ± 0.2 9.0 ± 0.2 0.875
Fiber 16.7 ± 8.7 16.6 ± 8.5 18.5 ± 9.5 0.016 17.0 ± 0.3 16.6 ± 0.5 17.9 ± 0.5 0.137
Micronutrients
Cholesterol (mg/day) 275 ± 120 276 ± 133 271 ± 130 0.756 278 ± 5 277 ± 7 264 ± 7 0.231
Calcium (mg/day) 999 ± 490 1040 ± 541 1021 ± 503 0.891 1020 ± 20 1039 ± 30 986 ± 28 0.425
Iron (mg/day) 9.8 ± 3.4 9.8 ± 3.4 10.6 ± 3.6 0.033 9.9 ± 0.1 9.9 ± 0.1 10.3 ± 0.1 0.032
Vitamin D (µg/day) 2.5 ± 1.8 2.5 ± 1.8 2.5 ± 2.2 0.924 2.5 ± 0.1 2.5 ± 0.1 2.4 ± 0.1 0.901
Specific foods (g/day)
Dairy 211 ± 190 228 ± 195 211 ± 164 0.725 217 ± 8 227 ± 13 199 ± 12 0.281
Red meat 38 ± 34 37 ± 34 39 ± 44 0.933 38 ± 2 37 ± 3 39 ± 2 0.911
Processed meats 10 ± 13 10 ± 13 9 ± 12 0.302 11 ± 1 10 ± 1 8 ± 1 0.119
Wholegrain 51 ± 56 50 ± 54 55 ± 53 0.133 53 ± 3 50 ± 4 54 ± 4 0.733
Fruits a 284 ± 245 298 ± 267 345 ± 303 0.040 289 ± 12 301 ± 18 333 ± 17 0.119
Fruits b 320 ± 262 335 ± 277 391 ± 317 0.016 325 ± 13 338 ± 19 378 ± 18 0.058
Fruits c 377 ± 289 396 ± 307 453 ± 339 0.012 382 ± 14 398 ± 21 442 ± 19 0.049
Vegetables 171 ± 110 171 ± 110 196 ± 148 0.043 171 ± 6 171 ± 8 194 ± 8 0.056
Fish d 30 ± 26 28 ± 22 31 ± 29 0.850 30 ± 1 28 ± 2 31 ± 2 0.569
Fish e 36 ± 28 34 ± 24 37 ± 33 0.578 36 ± 1 34 ± 2 37 ± 2 0.521
Dietary scores
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Table 2. Cont.
Bivariate Analysis Multivariable Analysis
Never Current Past p-Value Never Current Past p-Value
Mediterranean f 3.93 ± 1.48 4.04 ± 1.49 4.08 ± 1.45 0.476 3.94 ± 0.07 4.04 ± 0.11 4.06 ± 0.1 0.602
Mediterranean g 4.61 ± 1.86 4.84 ± 1.93 5.03 ± 1.87 0.038 4.63 ± 0.08 4.84 ± 0.13 5.00 ± 0.12 0.036
AHEI 33.3 ± 10.3 34.8 ± 9.9 35.0 ± 9.7 0.101 33.4 ± 0.5 34.7 ± 0.7 35.0 ± 0.7 0.104
Dietary patterns score
Meat and chips −0.29 ± 1.22 −0.45 ± 0.95 −0.40 ± 1.00 0.378 −0.29 ± 0.05 −0.42 ± 0.08 −0.42 ± 0.07 0.212
Fruits and vegetables 0.38 ± 1.55 0.50 ± 1.48 0.77 ± 1.71 0.017 0.43 ± 0.07 0.50 ± 0.10 0.68 ± 0.10 0.129
Fat and sugar 0.01 ± 1.44 −0.05 ± 1.33 0.09 ± 1.38 0.484 0.10 ± 0.05 −0.04 ± 0.08 −0.07 ± 0.07 0.146
a, fresh fruit only; b, fresh fruit + fresh juice; c, any fruit and fruit juice; d, fish, excluding fried; e, any fish; f, according to Trichopoulou et al. [23]; g, according to Vormund et al. [24]; AHEI,
alternative healthy eating index; MUFA, monounsaturated fatty acids; PUFA; polyunsaturated fatty acids; SFA; saturated fatty acids. Results are expressed as average ± standard deviation
for bivariate comparisons and as multivariable-adjusted average ± standard error for multivariable comparisons. For dietary patterns, negative scores indicate low adherence to the
dietary pattern, whereas positive scores indicate high adherence. Between-group comparisons performed using Kruskal-Wallis test (bivariate) and analysis of variance (multivariable).
Multivariable comparisons were performed adjusting for total energy intake (continuous), age (3 categories), education (3 categories), BMI categories (normal, overweight, obese),
sedentary level (yes/no) and diabetes (yes/no). Statistically significant p-values are highlighted in bold.
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Table 3. Compliance with dietary recommendations and dietary scores according to menopausal hormone therapy.
Bivariate Analysis Multivariable Analysis
Never Current Past p-Value Never Current Past
Guidelines
Fruits ≥ 2/day 209 (48.4) 102 (56.7) 136 (59.9) 0.011 1 (ref.) 1.36 (0.93 – 1.97) 1.35 (0.93 – 1.94)
Vegetables ≥ 3/day 39 (9.0) 13 (7.2) 24 (10.6) 0.504 1 (ref.) 0.74 (0.37–1.49) 1.06 (0.57–1.98)
Meat ≤ 5/week 296 (68.5) 128 (71.1) 155 (68.3) 0.788 1 (ref.) 1.06 (0.71–1.59) 0.92 (0.62–1.37)
Fish ≥ 1/week a 293 (67.8) 120 (66.7) 161 (70.9) 0.611 1 (ref.) 1.02 (0.70–1.50) 1.28 (0.88–1.88)
Fish ≥ 1/week b 196 (45.4) 80 (44.4) 101 (44.5) 0.966 1 (ref.) 0.99 (0.69–1.43) 1.04 (0.73–1.49)
Dairy ≥ 3/day 40 (9.3) 21 (11.7) 22 (9.7) 0.657 1 (ref.) 1.14 (0.63–2.06) 0.81 (0.44–1.49)
At least three guidelines a 129 (29.9) 64 (35.6) 92 (40.5) 0.020 1 (ref.) 1.24 (0.84–1.82) 1.40 (0.96–2.03)
At least three guidelines b 97 (22.5) 48 (26.7) 69 (30.4) 0.078 1 (ref.) 1.20 (0.79–1.84) 1.38 (0.92–2.07)
Dietary scores
Mediterranean c 59 (13.7) 29 (16.1) 38 (16.7) 0.516 1 (ref.) 1.20 (0.73–1.96) 1.38 (0.84–2.25)
Mediterranean d 76 (17.6) 38 (21.1) 51 (22.5) 0.281 1 (ref.) 1.29 (0.80–2.08) 1.42 (0.89–2.26)
AHEI 88 (20.7) 47 (26.1) 59 (26.6) 0.157 1 (ref.) 1.32 (0.85–2.03) 1.45 (0.94–2.24)
Dietary patterns
Meat and chips 115 (27.3) 37 (21.1) 52 (23.6) 0.245 1 (ref.) 0.75 (0.47–1.18) 0.81 (0.52–1.27)
Fruits and vegetables 93 (22.1) 43 (24.6) 68 (30.9) 0.049 1 (ref.) 0.99 (0.61–1.60) 1.23 (0.79–1.92)
Fat and sugar 115 (27.3) 36 (20.6) 53 (24.1) 0.209 1 (ref.) 0.48 (0.28–0.82) 0.47 (0.28–0.78)
a, all types of fish; b, excluding fried fish; c, according to Trichopoulou et al. [23]; d, according to Vormund et al. [24]; AHEI, alternative healthy eating index. Results are expressed as a
number (column percentage) for bivariate comparisons and as multivariable-adjusted odds ratio and (95% confidence interval) for multivariable comparisons. Between-group comparisons
were performed using chi-square (bivariate) and logistic regression (multivariable). Multivariable comparisons were performed adjusting for total energy intake (continuous), age (3
categories), education (3 categories), BMI categories (normal, overweight, obese), sedentary level (yes/no) and diabetes (yes/no). For dietary patterns, the results of the multivariate
comparisons are expressed as prevalence rate ratios and (95% confidence interval) of being in the last quartile relative to the other three. Significant (p < 0.05) odds-ratios are indicated in
bold. Statistically significant p-values are highlighted in bold.
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3.4. Menopause Hormone Therapy and Dietary Scores
Mean values of dietary scores according to MHT status, are summarized in Table 2. Both CU and
PU groups scored higher than NU for all three respective scores with their performance becoming
statistically higher for the revised Mediterranean dietary score. However, this difference did not
translate to a significantly higher odds ratio for being in the highest quintile for any of the examined
scores (Table 3).
3.5. Menopause Hormone Therapy and Dietary Recommendations
Compliance with dietary recommendations according to MHT status is illustrated in Table 3. The
bivariate analysis was remarkable for higher adherence of PU and to a lesser extent CU to the intake of
at least two fruits per day and the respect of at least three recommendations overall. Nevertheless,
these differences were no longer statistically significant after multivariate adjustment.
4. Discussion
In this cross-sectional analysis of the OsteoLaus cohort, no significant differences regarding dietary
intake were found according to MHT status. These results argue against a major role of caloric intake
and diet quality as possible mediators of the metabolic benefits of MHT.
4.1. Menopause Hormone Therapy, Weight Change and Caloric Intake
Though less extensively studied than the impact of MT on bone, a trend towards weight gain
and visceral fat accumulation is regularly found in longitudinal studies [5,29]. In the current study,
women taking MHT exhibited lower BMI, which was not explained by reduced TEI. These results
are in agreement with the few available human studies. Lovejoy et al. followed longitudinally 156
middle-aged women for four years, during which 51 became postmenopausal [29]. Postmenopausal
women selectively gained more VAT, a finding accompanied by decreased sleeping energy expenditure
and fat oxidation. No increase in caloric intake was observed during the MT. A large observational study
of healthy perimenopausal women (n = 907) detected postmenopausal weight gain independently of
MHT use, and without a concomitant increase of food intake [30]. The only available randomized,
double-blind, placebo-controlled trial that assessed energy intake was conducted in a small sample size
(n = 14 per group) and showed a non-significant 12% decrease in the MHT group over two years [31].
Caloric intake did not change after one year of MHT in two other small non-randomized studies [32,33].
In our study, a detailed analysis of macro- and micronutrient consumption did not reveal any
beneficial differences in CU, notably regarding SFA, which are traditionally considered as metabolically
deleterious. A link between estrogen and food composition is suggested by an animal study in
which oophorectomized rats exhibited hyperphagia with a predominant increase in dietary fat intake
secondary to estrogen deficiency [13]. In their longitudinal study across the MT, Lovejoy et al.
observed increased cholesterol and SFA intake during the first post-menopausal years [29]. Only a
few non-randomized and small-sized studies have assessed the effect of MHT on food composition
and did not detect any preferential intake of macronutrients [32–34]. It is possible that MHT does
not fully reverse the macronutrient preferences induced by menopause, due to significant differences
in comparison with pre-menopausal sex steroids levels. Notably, the majority of MHT regimes
implement continuous progestin doses, which is in contrast to the cyclic rise of progesterone in
naturally menstruating women. Progestins have been shown to antagonize estrogens and promote
binge eating, which may explain in part the observed differences [35].
4.2. Menopause Hormone Therapy and Diet Quality (Dietary Patterns, Scores, Recommendations)
The effect of estrogens on energy intake may not be limited to quantitative changes, but also
encompass changes in diet quality. In a large Australia study, the eating habits of more than 1500
participants aged 25 to 75 were monitored for more than 15 years [36]. The results highlighted that
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MHT is an independent factor associated with improved diet quality in women. Besides the analysis
of diet composition, diet quality can be assessed by other parameters, such as dietary patterns, dietary
scores, and compliance with dietary recommendations and. To our knowledge, this is the first study
evaluating the effect of MHT on such parameters.
Dietary patterns are a reliable indicator for an overall assessment of individual’s diet [37] and have
been validated to be strongly associated with chronic diseases such as type 2 diabetes [38]. Overall, CU
had a tendency to a lower adherence to both unhealthy patterns and a statistically significant higher
adherence to ‘fruits and vegetables’ pattern as compared to NU. But these differences disappeared after
adjustment for covariates. However, CU were significantly less likely to be in the highest quintile for the
‘fat and sugar’ pattern than NU, even after multivariate analysis. Interestingly, this pattern exhibited
strong correlations with total energy intake and saturated fat among CoLaus participants [22]. However,
in the absence of other concordant results on macronutrients analysis, and given the cross-sectional
design of the study, this isolated finding should be interpreted with caution. In addition, this pattern
was also present in PU which did not show any body composition advantage in our previous study [6].
Interestingly, a statistical difference (PU > CU > NU) was detected for the revised Mediterranean
score, while no difference was found for the other ones. The revised Mediterranean score is considered
to be more adapted to the Swiss population [24]. PU scored even higher than CU, an advantage
deriving from a preferential consumption of fruits and vegetables in this group.
In agreement with the majority of our results and following a multivariate adjustment, the
three groups did not differ regarding compliance with the Swiss dietary recommendations. There
are no previous reports regarding the effect of MHT or other estrogen-based preparations on this
outcome. Recently, an analysis of the PsyCoLaus cohort, which includes all the participants of the
OsteoLaus cohort, did not find any significant association between adherence to the same dietary
recommendations and the incidence of major depressive disorder [39].
4.3. Study Limitations and Strengths
This study has several limitations. First, excluded participants differed significantly from those
included in the analysis. Hence, it is possible that our findings do not apply to the whole population of
postmenopausal women. The cross-sectional setting of the study only allows establishing associations,
and no causal inferences can be drawn. As with all observation trials on MHT, it is possible that
some of the differences are due to a selection bias, given that women starting MHT tend to have a
healthier lifestyle [40]. However, there was no difference between groups in terms of education level
and smoking, two cardinal components of the ‘healthy women bias’ in previous studies. Information
regarding the type of MHT (estrogen-alone or estrogen/progestin) and the route of administration (oral,
transdermal, vaginal) was self-reported, preventing us from reliably assessing these factors and their
differential effect on body composition or nutrition. Further, we were unable to verify the adherence of
participants to MHT. The vast majority of participants were Caucasians, limiting the generalization of
the study’s conclusions to women of different ethnic backgrounds.
Conversely, our study has several strengths. To the best of our knowledge, this is the first
large-scale transversal study that thoroughly explores both quantitative and qualitative aspects of
dietary behavior according to MHT status. The implementation of several parameters (dietary patterns,
compliance with dietary guidelines, macro- and micronutrients estimations) allowed for a global
approach with different tools complementing each other. In addition, current and past MHT users
were distinguished. The large sample of the OsteoLaus cohort allowed for adequate statistical power.
All nutritional assessment was based on standardized tools which had been previously tested and
validated in the French-speaking population of Switzerland.
5. Conclusions
In conclusion, we did not observe any meaningful associations between MHT users and improved
eating habits. It is, therefore, unlikely that improved dietary behavior could explain the previously
Nutrients 2019, 11, 1930 11 of 13
observed reduction of total and visceral adiposity in current MHT users. Future research on the
relationship between estrogens and body composition should focus on other potential modifiers, such
as resting energy expenditure and physical activity.
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